vanilmandelic acid has been researched along with Cognition Disorders in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evers, LJ | 1 |
| Curfs, LM | 1 |
| Bakker, JA | 1 |
| Boot, E | 1 |
| da Silva Alves, F | 1 |
| Abeling, N | 1 |
| Bierau, J | 1 |
| Drukker, M | 1 |
| van Amelsvoort, TA | 1 |
1 other study available for vanilmandelic acid and Cognition Disorders
| Article | Year |
|---|---|
Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.
Topics: 22q11 Deletion Syndrome; Adult; Biomarkers; Case-Control Studies; Cognition Disorders; Dopamine; Fem | 2014 |